131 related articles for article (PubMed ID: 36929208)
1. Cardioprotective and anti-inflammatory effects of Caveolin 1 in experimental diabetic cardiomyopathy.
Gong W; Jiao Q; Yuan J; Luo H; Liu Y; Zhang Y; Chen Z; Xu X; Bai L; Zhang X
Clin Sci (Lond); 2023 Mar; 137(6):511-525. PubMed ID: 36929208
[TBL] [Abstract][Full Text] [Related]
2. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
3. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
[TBL] [Abstract][Full Text] [Related]
4. [Irisin Alleviates Inflammatory Injury in Diabetic Cardiomyopathy by Regulating NF-κB Pathway].
Zhang C; Huang J; Yang P; Liu X; Fan ZC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):545-551. PubMed ID: 37248582
[TBL] [Abstract][Full Text] [Related]
5. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
6. CAPE-pNO
Fan L; Xiao Q; Zhang L; Wang X; Huang Q; Li S; Zhao X; Li Z
Biomed Pharmacother; 2018 Dec; 108():1640-1650. PubMed ID: 30372866
[TBL] [Abstract][Full Text] [Related]
7. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
[TBL] [Abstract][Full Text] [Related]
8. Focal adhesion kinase induces cardiac remodeling through NF-κB-mediated inflammatory responses in diabetic cardiomyopathy.
Jin B; Wang J; Chen Y; Zuo W; Hong B; Li J; Huang F; Zhang M; Wang Y
Int Immunopharmacol; 2023 Jul; 120():110280. PubMed ID: 37216798
[TBL] [Abstract][Full Text] [Related]
9. Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88.
Zhang Q; Zhu W; Lou S; Bao H; Zhou Y; Cai Z; Ye J; Cui Y; Wang M; Jin L; Liang G; Luo W; Wang Y
Int Immunopharmacol; 2023 Nov; 124(Pt A):110863. PubMed ID: 37703787
[TBL] [Abstract][Full Text] [Related]
10. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
11. Adipose Tissue Caveolin-1 Upregulation in Obesity Involves TNF-α/NF-κB Mediated Signaling.
Al Madhoun A; Kochumon S; Haddad D; Thomas R; Nizam R; Miranda L; Sindhu S; Bitar MS; Ahmad R; Al-Mulla F
Cells; 2023 Mar; 12(7):. PubMed ID: 37048092
[TBL] [Abstract][Full Text] [Related]
12. Blockage of DCLK1 in cardiomyocytes suppresses myocardial inflammation and alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic mice.
Ji L; Yang X; Jin Y; Li L; Yang B; Zhu W; Xu M; Wang Y; Wu G; Luo W; Lee K; Liang G
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166900. PubMed ID: 37778481
[TBL] [Abstract][Full Text] [Related]
13. Costunolide alleviates hyperglycaemia-induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress.
Jin B; Chen Y; Wang J; Chen Y; Zhang M; Huang J; Wang Y
J Cell Mol Med; 2023 Mar; 27(6):831-845. PubMed ID: 36810875
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.
Ren XM; Zuo GF; Wu W; Luo J; Ye P; Chen SL; Hu ZY
PLoS One; 2016; 11(11):e0166740. PubMed ID: 27851811
[TBL] [Abstract][Full Text] [Related]
15. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Yao J; Li Y; Jin Y; Chen Y; Tian L; He W
Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494
[TBL] [Abstract][Full Text] [Related]
16. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress.
Chen X; Qian J; Wang L; Li J; Zhao Y; Han J; Khan Z; Chen X; Wang J; Liang G
Endocrine; 2018 Apr; 60(1):83-94. PubMed ID: 29392616
[TBL] [Abstract][Full Text] [Related]
17. β-elemene alleviates hyperglycemia-induced cardiac inflammation and remodeling by inhibiting the JAK/STAT3-NF-κB pathway.
Wang J; Qian C; Chen Y; Jin T; Jiang Y; Huang L; Fu X; Yang D; Jin L; Jin B; Wang Y
Phytomedicine; 2023 Oct; 119():154987. PubMed ID: 37531901
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
[TBL] [Abstract][Full Text] [Related]
19. Curcumin analog JM-2 alleviates diabetic cardiomyopathy inflammation and remodeling by inhibiting the NF-κB pathway.
Wang M; Jin L; Zhang Q; Zhu W; He H; Lou S; Luo W; Han X; Liang G
Biomed Pharmacother; 2022 Oct; 154():113590. PubMed ID: 36057221
[TBL] [Abstract][Full Text] [Related]
20. Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy.
Zuo GF; Ren XM; Ge Q; Luo J; Ye P; Wang F; Wu W; Chao YL; Gu Y; Gao XF; Ge Z; Gao HB; Hu ZY; Zhang JJ; Chen SL
J Mol Cell Cardiol; 2019 May; 130():170-183. PubMed ID: 30998977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
